Natick, MA, United States of America

Corey E Bienstock



Average Co-Inventor Count = 13.3

ph-index = 8

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: The Innovator Behind Bicyclic Compounds: Corey E. Bienstock

Introduction

Corey E. Bienstock is a prominent inventor based in Natick, Massachusetts, known for her significant contributions to the field of medicinal chemistry. With a total of 12 patents to her name, her work has focused on developing novel bicyclic compounds aimed at treating diseases mediated by RORgammaT.

Latest Patents

Among her latest patents, Corey has developed a series of compounds including tetrahydronaphthyridine, benzoxazine, and aza-benzoxazine. These compounds are designed for the inhibition of RORgamma activity, which plays a crucial role in various disease conditions. The details of the inventions provide formulations comprising these bicyclic heterocyclic compounds and their pharmaceutically acceptable salts. Notably, the invention also outlines methods for utilizing these compounds in treating diseases linked to RORgammaT, showcasing the potential impact of her work in pharmaceuticals.

Career Highlights

Corey has a rich career history, having worked with reputable companies in the industry. She has been associated with Merck Sharp & Dohme Corporation, where her research contributed to the development of innovative therapeutic solutions. Additionally, her role at Lycera Corporation enabled her to explore advanced concepts in medicinal chemistry, further solidifying her reputation as an accomplished inventor.

Collaborations

Corey’s innovation journey has been enhanced by collaborations with esteemed colleagues, including Kenneth Jay Barr and John K. MacLean. These partnerships have facilitated a dynamic exchange of ideas and expertise, enriching the research environment and leading to groundbreaking developments in her field.

Conclusion

Corey E. Bienstock stands out as a trailblazer in the realm of bicyclic compound inventions. Her dedication to advancing medicinal chemistry, through innovative patent developments and significant collaborations, underscores the importance of her contributions to the scientific community and the treatment of complex diseases. As her work continues to evolve, Corey remains a key figure to watch in the landscape of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…